Outlive: The Art and Science of a Longer, Better Life

Attia calls Medicine 2.0 the model most people know: you live normally until a symptom shows up, you go to the clinic or your insurance network, get a diagnosis, and start treatment. This model is excellent for emergencies like a broken bone, a severe infection, or an inflamed appendix, but it fails precisely with chronic, slow diseases, which take decades to form and only give a signal once they have already done major damage.

The Medicine 3.0 proposal is to look at each person's history, biomarkers, and family risk long before symptoms appear, acting years ahead of time. For Attia himself, this includes testing still-experimental tools on himself, such as rapamycin, a drug originally studied to prevent transplant rejection and now also investigated for its possible effect on the cellular autophagy linked to aging.

He is clear that this is his own personal bet, not a recommendation for use, and that any decision like this requires serious medical follow-up, testing, and constant supervision. It is best to understand Medicine 3.0 as a direction of thinking, not as a package of tests to order on your own at the lab.

Attia dubs as the Four Horsemen the four categories of chronic disease responsible for most deaths in developed countries: atherosclerotic cardiovascular disease, cancer, neurodegenerative diseases such as Alzheimer's, and metabolic dysfunction, which includes type 2 diabetes.

The central point is that these horsemen rarely appear out of nowhere. They develop slowly, often over twenty or thirty years, in silence, while the person feels fine day to day, riding a packed bus in the morning and coming home tired at night with no idea that something is already underway inside.

That is why the author argues for knowing the enemy by name before defending yourself against it. Each horseman has its own mechanism, risk factors, and prevention window, and the next sections take up each one separately.

Atherosclerosis, the progressive clogging of the arteries by fatty plaques, starts much earlier than most people imagine, sometimes in youth, according to autopsy studies cited in the book. The problem is that it doesn't hurt and doesn't warn you, showing itself only when it is already advanced, in a heart attack or stroke that seems to come out of nowhere.

Attia argues that LDL cholesterol and other related particles deserve monitoring by a professional well before the age at which that kind of test is usually ordered today, because the damage accumulates over decades, not in a few years.

The good news is that a large part of cardiovascular risk is modifiable: regular exercise, controlling hypertension, not smoking, and a balanced diet have consistent scientific backing, an area where medical consensus is broad and doesn't depend on the author's personal bets.